Skip to main content
. 2020 Aug 11;12:1758835920942378. doi: 10.1177/1758835920942378

Figure 5.

Figure 5.

Number of patients who reach disease control stratified by neutrophil–lymphocyte ratio (NLR). In the χ2 test patients were divided into two groups (NLR ⩽1.93 and NLR >1.93). Patients in the NLR >1.93 group showed a significantly higher progressive disease rate than patients in the NLR ⩽1.93 group.